Thirty-two stallions were used to determine the effect of anabolic steroids on reproductive function. Stallions were assigned to one of the four treatments: 1) .23 ml sesame oil/kg of body weight (BW; control, C); 2) 4.4 mg boldenone undecylenate/kg BW (4E); 3) 1.1 mg boldenone undecylenate/kg BW (1E) and 4) 1.1 mg nandrolone decanoate/kg BW (D). Injections were given at 3-wk intervals for 15 wk. Semen was collected every other day for 3 wk before the first injection and at the same frequency during d 85 through 105 (d 0 = day of first injection). Libido was assessed on the basis of reaction time. Total scrotal width was determined every 2 wk. Serum was obtained at various intervals and analyzed for concentrations of luteinizing hormone (LH). Portions of testicular parenchyma were used to determine spermatid reserves and to permit quantitative histological evaluation of spermatogenesis. Gel, gel-free and total seminal volumes and pH were not affected (P>.05) by steroid treatment. However, spermatozoal motility, spermatozoal concentration and total sperm/ejaculate were severely lowered (P<.05) by all anabolic steroid treatments. Total scrotal width for stallions in the D, 4E and 1E groups was less (P<.05) than that of C stallions by wk 5. 61.6%, respectively, of that for the controls. Spermatozoal production was altered, as evidenced by smaller (P<.05) numbers of spermatids/testis and primary spermatocytes for all treated groups than for the controls. Anabolic steroid treatment had no effect (P>.05) on erection time, time to first mount, ejaculation time or number of mounts/ejaculation. Treatment with anabolic steroids resuited in a depression in concentration of LH in all treatment groups.
Introduction
Although anabolic steroids are used in horses to improve performance, accelerate growth, increase appetite and(or) enhance libido, data substantiating these beneficial effects are lacking. Anabolic steroids are derivatives of testosterone or related compounds and are, to some extent, androgenic. Administration of androgens to normal males of several species reduced testis size and impaired spermatogenesis (Moore and Price, 1938; Rubinstein and Kurland, 1941; Ludwig, 1950; Berndtson et al., 1974 Berndtson et al., , 1979 and inhibited the secretion of luteinizing hormone (Desjardins et al., 1973; Mauss et al., 1975) . Bullard and Kerr (1972) reported that the administration of boldenone undecylenate to pubescent stallions did not affect the seminal characteristics. Unfortunately, the results of that trial were confounded by hemicastration, onset of puberty and season. More recently, Carson and Thompson (1979) examined the testes and semen from six pubescent stallions that had received 1.1 mg boldenone undecylenate/kg body weight (BW) monthly for 5 mo and reported no effect on spermatozoal morphology or spermatogenesis. However, no quantitative method of assessing spermatogenesis was used.
The purpose of this study was to determine 576 JOURNAL OF ANIMAL SCIENCE, Vol. 54, No. 3, 1982 if anab91ic steroid treatment had detrimental effects on semirial quality, spermatozoal output and production, testicular size, sexual behavior and concentration of luteinizing hormone (LH) in serum of stallions.
Materials and Methods
General. Thirty-two stallions of light-horse type, 2-to 4-yr old and weighing 375 to 520 kg were used. Stallions were selected that had testes of normal size and consistency, spermatozoal output of at least 1 x 109 on an every other day basis (after stabilization of spermatozoal reserves) and spermatozoal motility of at least 40%. Stallions were assigned to one of four treatments: 1) .23 ml of sesame oil/kg BW (controls, C); 2) 4.4 mg boldenone undecylenate4/kg BW (4E); 3) 1.1 mg boldenone undecylenate/kg BW (1E), and 4) 1.1 nag nandrolone decanoate s/kg BW (D). The dosage of 1.1 nag boldenone undecylenate/kg BW is the recommended dosage for mares and geldings. Injections were given im into the neck at 3-wk intervals for 15 wk (total of six injections). Because the 32 stallions were not all available at one time, the experiment was conducted in three replicates of 14, 9 and 9 stallions. This asymmetry of replicate size was due to the loss of two stallions for replicate 2; one due to abnormal sexual behavior and the other to injury. The addition of one stallion to replicate 2 and 3 provided an equal number of stallions in each treatment group. Seminal collections for stallions in replicates 1, 2 and 3 began (d -22) (Pickett and Back, 1973) . Libido was assessed by the following criteria: 1) time required for a stallion to obtain an erection after presentation to a "tease mare", 2) time to first mount, 3) time from first mount to ejaculation and 4) number of mounts/ejaculation.
Two seminal smears were prepared with eosin nigrosin stain from each of five ejaculates obtained during the pretreatment and treatment periods. One hundred spermatozoa were examined per slide and the percentages of the following morphologic characteristics were recorded: head abnormalities, separated heads, midpiecr abnormalities, tail abnormalities, proximal and distal cytoplasmic droplets and normal spermatozoa.
Testes Measurements. Total serotal width was determined every 2 wk throughout the experiment as described by Gebauer et al. (1974) . Five repeated measurements were taken by each of two technicians on 2 consecutive days. Measurements taken during the pretreatment period provided a baseline for each horse. Blood Sampling. Jugular blood samples (~35 ml) taken twice daily (0730 and 1630 h) on d -5, -3, -1, 3, 9, 15, 21, 42, 57, 72, 81 and 104 were used to monitor the long-term effect of treatment on concentrations of LH. Additional samples were obtained every 6 h on the day preceding treatment, day of treatment and for 2 d after the first, fourth and sixth treatments. These samples permitted assessment of short-term changes in LH, as well as differences in LH response to treatment over time. All samples were stored at 5C for 24 to 36 h, centrifuged, and serum removed and stored at -20C until assayed for LH by radioimmunoassay (Nett et al., 1975) . Spermatozoal Production. Stallions were bilaterally castrated 1 wk after the last injection (d 112). Immediately after castration, the testes were weighed, the tunica albuginea was removed and weighed and the weight of the testicular parenchyma was determined by subtraction. A portion of testicular parenchyma was frozen for determination of spermatid reserves in testicular homogenates (Amann and Almquist, 1961) . Additional portions of testicular parenchyma were fixed SQUIRES ET AL.
and processed for quantitative histological evaluation of spermatogenesis (Brendtson et al., 1974; Berndtson, 1977) . Statistical Analyses 9 Within a replicate, stallions were ranked on the basis of their pretreatment spermatozoal output and assigned to blocks of four animals each. Incomplete blocks were balanced subsequently by staUions from additional replicates. This resulted in a total of eight blocks of four stallions each, one in each treatment group. Characteristics measured only once, i.e., testes weight, testicular histology and spermatid reserves were subjected to a one-way analysis of variance. Seminal and behavioral characteristics, concentrations of LH and scrotal width were analyzed by an analysis of covariance, with pretreatment means used as covariates. When significant effects were observed in the analysis, differences among means were tested by LSD criterion (Steel and Torrie, 1960) .
Results and Discussion
Seminal Characteristics. The seminal characteristics of ejaculates collected during the pretreatment and treatment periods are summarized in table 1. Although gel, gelfree and total seminal volumes decreased during the study (P<.05), these were not affected (P>.05) by steroid treatment. The decreases noted from the beginning to the end of the experiment were probably due to season (Pickett et al., 1976) . Seminal pH was also unaffected (P>.05) by steroid treatment. Berndtson et al. (1979) did not observe an effect of testosterone propionate on seminal volumes or pH.
Spermatozoal motility, concentration and total sperm/ejaculate were lowered (P<.05) by all anabolic steroid treatments. Motility of spermatozoa in ejaculates from 4E-and 1E-treated stallions was 21 and 34% lower (p<.01) than that for control stallions, while treatment with nandrolone decanoate drastically reduced (P<.05) the percentage of progressively motile spermatozoa below that for all other groups (table 1) . Spermatozoal concentration and total sperm/ejaculate were lower (P<.05) for stallions in the 4E and D groups than for stallions in the 1E group, which was lower (P<.05) than the controls. Total sperm/ejaculate for control stallions was 7.3 x 109 during the pretreatment period and 5.0 x 109 for the treatment period. This reduction in sperma- tozoal output (32%) was attributed to season. Thus, one would have predicted a similar decrease for steroid-treated stallions. However, spermatozoal output for stallions in the 4E, 1E and D groups was reduced by 77, 54 and 90%, respectively, compared to pretreatment means.
The percentage of morphologically normal spermatozoa in ejaculates obtained during the treatment period was lower (P<.05) for stallions in the D group (52.6%) than for stallions in the control group (68.3%), 4E group (62.0%) or 1E group (63.2%). The most common alteration in morphology of spermatozoa in response to treatment was an increased percentage of separated heads. This increase was as much as fivefold for several stallions in the D, 4E and 1E groups. The harmful effect of androgen administration on spermatozoal morphology has previously been demonstrated both in the stallion (Squires et al., 1981) and in humans (Mauss et al., 1975) .
Total scrotal width of stallions in the D, 4E and 1E groups was less (P<.05) than that of C stallions by 5 wk after initiation of treatment. In addition, total scrotal width of 4E-and D-treated stallions was less (P<.01) than that of stallions in the 1E group during the ninth through the 15th wk of treatment. Testes size continued to decrease in all treatdd stallions until the 1 lth wk of treatment, after which no further decrease was noted (figure 1).
Although the reduction in testes size was greatest in the 4E and D groups, the administration of 1.1 mg boldenone undecylenate/kg BW (1E) to stallions in the nonbreeding season (replicate 3) caused a severe reduction in scrotal width. In contrast, the administration of this steroid (1E) to stallions during the summer had little effect on total scrotal width. Thus, there appeared to be a synergistic effect of season and anabolic steroid treatment on testes size in this group. Although scrotal width was severely reduced in most anabolic steroid-treated stallions, some stallions had measurements adequate to pass a breeding soundness examination. This may partly explain why other investigators had not previously detected detrimental effects of these compounds.
The decrease in testicular size was reflected in testicular weight at castration (table 2) . Paired testes weight and parenchyma weight were lower (P<.05) for stallions given anabolic steroids than for those of controls. Testes weight of stallions in the 1E group was greater (P<.05) than that of the D and 4E stallions. The mean testes weight for stallions in the 4E (128 g) and D (114 g) groups was less than one-half the mean for C stallions (285 g).
Spermatozoal production was also severely reduced by anabolic steroid treatment (table 2). a'bMeans in the same row bearing different superscripts differ (P<.0$).
The number of spermatids/g of testes for both the 4E and D stallions was lower (P<.05) than that for C-and 1E-treated stallions. The reduction in spermatids/g of testis in response to the 1E treatment was marginal (P<.10). However, due to the severe reduction in testes size, the number of spermatids/testis was lower (P<.05) for all treated stallions compared to controls. A reduction in spermatid reserves in the testis, a direct measure of spermatozoal production, ultimately results in decreased spermatozoal output (table 1) . The correlation between daily sperm production and daily sperm output in the stallion is .80 (Swierstra et al., 1975) . When the testes were evaluated histologically, it was evident that all anabolic steroid treatments reduced (P<.05) the number of developing germ cells, other than type A spermatogonia (table 3) . This finding was in contrast to that of Carson and Thompson (1979) , who examined histologic sections of testicular tissue from boldenone undecylenatetreated stallions and reported that spermatogenesis was proceeding normally. This discrepancy between the two studies may be related to difference in methodology used. In our study, conclusions were based on several quantitative techniques such as: spermatid reserve counts, cell counts and sperm/ejaculate.
Sexual Bebavior. Treatment with anabolic steroids had no effect (P>.05) on erection time, time to first mount, ejaculation time or the number of mounts/ejaculation (table 4). The administration of testosterone propionate was also ineffective in improving libido in the stallion (Hoyer, 1978) . Thus, it must be concluded that testosterone or anabolic steroids at the dosages reported have no effect, beneficial or otherwise, on sexual behavior of normal stallions.
Concentrations of Luteinizing Hormone.
Concentrations of LH in the D-and 4E-treated stallions were depressed (P<.05) by 48 to 54 h after the initial injection, whereas, values for the 1E stallions were higher (P<.05) than those of C stallions at 48, 54 and 66 h postinjection (figure 2). This resulted in a treatment x period interaction (P< 01). There was a precipitous drop in concentrations of LH in the C stallions after the initial injection. The explanation for this decline is not readily apparent. Mean concentrations of LH in the Dand 4E-treated stallions were also lower (P<.05) than those of controls on d 3, 15, 42 and 104 (figure 3); concentrations of LH in the 1E group were greater (P<.05) than those for the 4E-and D-treated stallions until 42 d after the initial injection. Treatment with 1.1 mg boldcnone undecylcnate/kg BW did result in lower (P<.05) concentrations of LH, compared to those of controls, on d 42, 81 and 104 (figure 3). This delayed decline in concentrations of LH in the 1E-treated stallions was responsible for the significant treatment x period interaction. Baseline concentrations of LH remained depressed during the 3-wk interval between injections, and concentrations of LH did not change (P>.05) in response to the fourth or sixth injection. In addition, peaks of LH in both the D-and 4E-treated stallions appeared to be suppressed in samples obtained after the fourth and sixth injection. In contrast, the pattern of LH release in serum of C stallions was similar throughout the treatment period. For example, daily peaks in LH noted after the initial injection were still evident after the sixth injection. Squires et al. (1977) ference in severity of response to treatment was also evident in spermatozoal output and seminal quality. Thus, the detrimental effects of anabolic steroid treatment on the potential fertility of young stallions may in part be mediated by decreased concentrations of LH in serum.
The administration of anabolic steroids to young stallions proved highly detrimental to seminal quality, spermatozoal output and production, testis size and concentrations of LH in serum. In addition, there was no beneficial effect of anabolic steroid treatment on libido. Therefore, the use of these compounds in breeding stallions is contraindicated.
